Jens Kastrup Selected Research

Myocardial Infarction

6/2022	Meta-Analysis of Percutaneous Endomyocardial Cell Therapy in Patients with Ischemic Heart Failure by Combination of Individual Patient Data (IPD) of ACCRUE and Publication-Based Aggregate Data.
1/2022	Five-year follow-up of intracoronary autologous cell therapy in acute myocardial infarction: the REGENERATE-AMI trial.
10/2021	The Initial Cardiac Tissue Response to Cryopreserved Allogeneic Adipose Tissue-Derived Mesenchymal Stromal Cells in Rats with Chronic Ischemic Cardiomyopathy.
10/2020	The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: the BAMI trial.
5/2018	Angiogenesis PET Tracer Uptake (68Ga-NODAGA-E[(cRGDyK)]₂) in Induced Myocardial Infarction and Stromal Cell Treatment in Minipigs.
1/2018	Retention and Functional Effect of Adipose-Derived Stromal Cells Administered in Alginate Hydrogel in a Rat Model of Acute Myocardial Infarction.
1/2017	Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trial.
6/2016	Angiogenesis PET Tracer Uptake ((68)Ga-NODAGA-E[(cRGDyK)]₂) in Induced Myocardial Infarction in Minipigs.
1/2016	Cardiovascular magnetic resonance imaging of myocardial oedema following acute myocardial infarction: Is whole heart coverage necessary?
4/2015	Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jens Kastrup Research Topics

Disease

31	Coronary Artery Disease (Coronary Atherosclerosis) 10/2021 - 06/2003
29	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 06/2003
25	Myocardial Infarction 06/2022 - 01/2006
17	Coronary Disease (Coronary Heart Disease) 10/2021 - 01/2006
15	Heart Failure 06/2022 - 07/2002
15	ST Elevation Myocardial Infarction 11/2021 - 02/2005
12	Heart Diseases (Heart Disease) 10/2020 - 01/2006
10	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2003
10	Infarction (Infarctions) 10/2018 - 02/2005
8	Inflammation (Inflammations) 01/2020 - 03/2010
6	Fibrosis (Cirrhosis) 10/2021 - 04/2007
6	Pathologic Constriction (Stenosis) 01/2018 - 01/2002
5	Hypertension (High Blood Pressure) 06/2022 - 09/2011
5	Angina Pectoris 10/2021 - 01/2002
5	Acute Coronary Syndrome 01/2020 - 01/2003
5	Ischemia 10/2018 - 04/2006
4	Coronary Stenosis (Coronary Artery Stenosis) 01/2020 - 07/2014
4	Hypoxia (Hypoxemia) 01/2017 - 03/2011
3	Diabetes Mellitus 06/2022 - 06/2012
3	Disease Progression 10/2021 - 12/2013
3	Stroke (Strokes) 10/2021 - 06/2012
3	Stable Angina 01/2021 - 09/2011
3	Ventricular Remodeling 09/2013 - 09/2008
2	Lung Diseases (Lung Disease) 06/2012 - 04/2010
2	Hyperplasia 03/2010 - 07/2006
1	Hyperlipidemias (Hyperlipidemia) 06/2022
1	Xerostomia 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022
1	Chronic Disease (Chronic Diseases) 10/2021
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2021
1	Necrosis 01/2020
1	Unstable Angina 01/2017
1	Infertility (Sterility) 11/2016

Drug/Important Bio-Agent (IBA)

19	Biomarkers (Surrogate Marker)IBA 10/2021 - 08/2008
13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 06/2003
13	Clarithromycin (Biaxin)FDA LinkGeneric 01/2020 - 01/2006
13	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2013 - 04/2005
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 02/2010
6	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 05/2004
6	C-Reactive ProteinIBA 07/2013 - 02/2011
5	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 07/2014
4	Proteins (Proteins, Gene)FDA Link 12/2020 - 06/2003
4	CytokinesIBA 11/2015 - 08/2006
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2010 - 01/2003
3	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 01/2020 - 01/2011
3	OsteoprotegerinIBA 01/2020 - 11/2014
3	CreatinineIBA 10/2018 - 09/2011
3	Rubidium-82IBA 01/2018 - 07/2014
3	pro-brain natriuretic peptide (1-76)IBA 01/2017 - 06/2012
2	Dipyridamole (Persantine)FDA LinkGeneric 01/2021 - 02/2017
2	EndostatinsIBA 01/2020 - 01/2019
2	Troponin T (Troponin T1)IBA 01/2020 - 10/2018
2	Cathepsin BIBA 01/2020 - 11/2018
2	Lipocalin-2IBA 01/2020 - 01/2006
2	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 05/2018 - 06/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 09/2013
2	AntibodiesIBA 11/2017 - 04/2010
2	CalciumIBA 01/2016 - 09/2004
2	Natriuretic PeptidesIBA 07/2013 - 07/2002
2	Interleukin-6 (Interleukin 6)IBA 01/2012 - 04/2007
2	Messenger RNA (mRNA)IBA 01/2012 - 04/2007
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2010 - 01/2008
1	Proteoglycans (Proteoglycan)IBA 10/2021
1	Cytidine Triphosphate (CTP)IBA 01/2021
1	Small Nucleolar RNA (snoRNA)IBA 08/2019
1	MicroRNAs (MicroRNA)IBA 08/2019
1	ferric oxide (iron oxide)IBA 01/2019
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 01/2019
1	Collagen Type XVIII (Type XVIII Collagen)IBA 01/2019
1	cathepsin SIBA 11/2018
1	Cardiovascular AgentsIBA 11/2018
1	Trinitrotoluene (TNT)IBA 10/2018
1	Phosphotransferases (Kinase)IBA 10/2018
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2018
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2018
1	HydrogelsIBA 01/2018
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2018
1	CollagenIBA 01/2018
1	AlginatesIBA 01/2018
1	EpitopesIBA 01/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2017
1	Bovine Serum AlbuminIBA 01/2017
1	CyclinsIBA 01/2017
1	GalactosidasesIBA 01/2017
1	EndotoxinsIBA 11/2016
1	GadoliniumIBA 11/2016
1	HDL CholesterolIBA 03/2016

Therapy/Procedure

37	Therapeutics 06/2022 - 06/2003
12	Percutaneous Coronary Intervention 01/2017 - 02/2005
11	Injections 01/2020 - 08/2005
8	Cell- and Tissue-Based Therapy (Cell Therapy) 06/2022 - 09/2008
8	Stents 03/2013 - 02/2003
5	Hematopoietic Stem Cell Mobilization 03/2013 - 04/2006
4	Transplantation 01/2019 - 03/2011
2	Aftercare (After-Treatment) 01/2022 - 12/2013
1	Radiotherapy 01/2022
1	Patient Readmission 01/2022
1	Ligation 10/2021
1	Immunomodulation 12/2020